期刊文献+

降钙素原和免疫炎性因子在粒细胞减少的恶性血液病菌血症患者中的临床应用价值 被引量:22

Application Value of Procalcitonin and Immune Inflammatory Factors for Prediction of Bacteriemia in Patients with Hematologic Malignancy Combined with Febrile Neutropenia
下载PDF
导出
摘要 本研究探讨降钙素原(procalcitonin,PCT)、免疫炎性因子C-反应蛋白(C-reactive protein,CRP)、血清淀粉样蛋白A(serum amyloid A,SAA),白介素-6(interleukin-6,IL-6)对中性粒细胞减少的恶性血液病菌血症患者的诊断价值。对四川大学华西医院2011年3月-2012年10月确诊为恶性血液病伴发热的1253例住院患者进行了回顾性分析,按照严格的纳入排除标准选取297例,以血培养作为金标准分为菌血症组和非菌血症组,分析数据,评价诊断效能。结果表明:在恶性血液病粒细胞减少的患者中,菌血症组患者血清PCT、CRP、IL-6以及SAA水平较非菌血症组增高,差异具有统计学意义(P<0.05)。PCT的曲线下面积(AUC)为0.974(P<0.05),明显优于CRP(AUC=0.681,P<0.05)、IL-6(AUC=0.661,P<0.05)和SAA(AUC=0.605,P<0.05),差异具有统计学意义。当PCT的cut-off值为1.06 ng/ml时,灵敏度达95.8%,特异度达92.1%,Youden指数为0.879,阴、阳性预测值分别为97.8%和85.0%,阴、阳性似然比分别为0.05和12.2,均明显优于CRP、IL-6和SAA。结论:在恶性血液病中性粒细胞减少合并细菌感染的患者中,血清PCT的诊断效能优于传统免疫炎性因子CRP、IL-6、SAA。PCT可作为预测细菌感染的一个快速可靠的指标,为临床合理使用抗生素、降低死亡风险提供实验室依据。 This study was purposed to evaluate the diagnositic value of procalcitonin ( PCT), C-reactive protein, interleukin-6 (IL-6), serum amyloid A (SAA) for bacteremia in patients with hematologic malignancy combined with febrile neutropania. The total of 297 patients with hematologic malignancy combined with febrile neutropania were analyzed retrospectively from 1253 patients admitted to West China hospital of Sichuan University from March 2011 to Octerber 2012. They were divided into sepsis group (n = 95 ) and non-sepsis group (n = 202 ) according to blood culture. The results showed that the levels of PCT, CRP, IL-6 and SAA in sepsis group were higher than those in non-sepsis group, and there was statistically significant difference between these two groups ( P 〈 0.05 ). The PCT had an AUC value of 0. 974 ( P 〈 0.05), and obviously higher than that of CRP ( AUC = 0. 681, P 〈 0.05 ), IL-6 ( AUC = 0. 661, P 〈0.05) and SAA (AUC =0. 605, P 〈0.05). When PCT had cut-off value of 1.06 ng/ml, sensitivity of 95.8%, specificity of 92.1%, and the Youden indicator of 0. 879, the negative and positive predictive values were 97.8% and 85.0% respectively, the negative and positive likelihood ratios were 0.05 and 12.5 respectively, and all significanlly higher than that of CRP, IL-6 and SAA. It is concluded that for patients with hematologic malignancy combined with febrile neutropenia and bacterial infection, the diagnostic value of serum PCT is superior to that of immune inflammatory factors(CRP, 1L-6 and SAA), the PCT can predict the bacterium infection, provide laboratory evidence for rational antimicrobial drug usage and mortality reduction.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第5期1296-1300,共5页 Journal of Experimental Hematology
关键词 降钙素原 免疫炎性因子 血培养 菌血症 粒细胞减少 procalcitonin immune inflammatory factor blood culture bacteremia neutropenia
  • 相关文献

参考文献15

  • 1Neofytos D,Lu K,Hatfield-Seung A,et al.Epidemiology,outcomes,and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy.Diagn Microbiol Infect Dis,2013 ;75 (2):144-149.
  • 2Pierrakos C,Vincent JL.Sepsis biomarkers:a review.Crit Care,2010; 14(1):R15.
  • 3Vaschetto R,Protti A.Biomarkers of sepsis in long-term critically ill patients.Minerva Anestesiol,2010 ; 76 (10):771-772.
  • 4Hughes WT,Armstrong D,Bodey GP,et al.2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Clin Infect Dis,2002;34(6):730-751.
  • 5邵青,沈定霞.造血干细胞移植后侵袭性真菌感染的诊断和治疗进展[J].中国实验血液学杂志,2009,17(6):1619-1623. 被引量:6
  • 6郭智,陈惠仁,刘晓东,边佳明,何学鹏,楼金星,陈鹏,杨凯,刘丹,张媛.异基因造血干细胞移植后发生巨细胞病毒感染的临床分析[J].中国实验血液学杂志,2012,20(4):971-974. 被引量:20
  • 7Jeddi R,Ghédira H,Ben Amor R,et al.Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections.Hematology,2011 ; 16 (3):160-165.
  • 8Meisner M,Reinhart K.Biomarkers in the critically ill patient:procalcitonin.Crit Care Clin,2011 ;27 (2):253-263.
  • 9Carnino L,Betteto S,Loiacono M,et al.Procalcitonin as a predictive marker of infections in chemoinduced neutropenia.J Cancer Res Clin Oncol,2010;136(4):611-615.
  • 10Koivula I,Juutilainen A.Procalcitonin is a useful marker of infection in neutropenia.Leuk Res,2011 ;35 (10):1288-1289.

二级参考文献13

  • 1张䶮莉,周健,魏旭东,蒋东霞,程爱民,胡杰英,郭淑利,朱兴虎,宋永平.不同方法检测同种异基因造血干细胞移植受者巨细胞病毒感染的探讨[J].中国实验血液学杂志,2007,15(3):558-562. 被引量:5
  • 2刘开彦.造血干细胞移植患者巨细胞病毒感染的诊治进展[J].中国实用内科杂志,2007,27(20):1597-1598. 被引量:9
  • 3Munoz-Cobo B,Solano C,Costa E,et al.Dynamics of cytomegalov-irus(CMV)plasma DNAemia in initial and recurrent episodes of ac-tive CMV infection in the allogeneic stem cell transplantation setting:implications for designing preemptive antiviral therapy strategies.BiolBlood Marrow Transplant,2011;17(11):1602-1611.
  • 4Borchers S,Luther S,Lips U,et al.Tetramer monitoring to assessrisk factors for recurrent cytomegalovirus reactivation and reconstitu-tion of antiviral immunity post allogeneic hematopoietic stem celltransplantation.Transpl Infect Dis,2011;13(3):222-236.
  • 5Ruiz-Camps I,Len O,de la Camara R,et al.Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haemato-poietic stem cell transplant recipients.Antivir Ther,2011;16(7):951-957.
  • 6Ichihara H,Nakamae H,Hirose A,et al.Immunoglobulin prophy-laxis against cytomegalovirus infection in patients at high risk of in-fection following allogeneic hematopoietic cell transplantation.Trans-plant Proc,2011;43(10):3927-3932.
  • 7Cantoni N,Hirsch HH,Khanna N,et al.Evidence for a bidirection-al relationship between cytomegalovirus replication and acute graft-versus-host disease.Biol Blood Marrow Transplant,2010;16(9):1309-1914.
  • 8Kekik C,Besisik SK,Seyhun Y,et al.Relationship between HLAtissue type,CMV infection,and acute graft-vs-host disease after allo-geneic hematopoietic stem cell transplantation:single-center experi-ence.Transplant Proc,2009;41(9):3859-3862.
  • 9Jang JE,Hyun SY,Kim YD,et al.Risk factors for progression fromcytomegalovirus viremia to cytomegalovirus disease after allogeneichematopoietic stem celltransplantation.Biol Blood Marrow Trans-plant,2012;18(6):881-886.
  • 10Park SY,Lee SO,Choi SH,et al.Efficacy and safety of low-doseganciclovir preemptive therapy in allogeneic haematopoietic stem celltransplant recipients compared with conventional-dose ganciclovir:aprospective observational study.Antimicrob Chemother,2012;67(6):1486-1492.

共引文献23

同被引文献159

  • 1顾伟英,谢晓宝,曹祥山,华铮,华晓莹.急性白血病患者化疗后合并败血症临床分析[J].临床荟萃,2004,19(14):801-802. 被引量:11
  • 2夏凌辉,邹萍,胡俊斌,方峻,游泳,郭涛,刘芳,张纯,江汇娟,宋善俊.造血干细胞移植后并发感染121例的临床分析[J].中华器官移植杂志,2006,27(11):685-688. 被引量:10
  • 3张之南.血液病诊断及疗效标准[M].北京:科学出版社,1999.270-271.
  • 4Kumar A. Optimizing antimicrobial therapy in sepsis and septic shock [J] . Crit Care Clin, 2009, 25 (4) : 733 -751.
  • 5Limper M, de Kruif MD, Duits A J, et al. The diagnostic role of procalcitonin and other biomarkers in discriminating iffec- tious from non - infectious fever [J] . J Infect, 2010, 60 (6) : 409 -416.
  • 6van der Poll T,Levi M.Crosstalk between inflammation and coagulation:the lessons of sepsis.Curr Vasc Pharmacol,2012;10(5):632-638.
  • 7Levi M,van der Poll T.Inflammation and coagulation.Crit Care Med,2010;38(2):S26-34.
  • 8O'Brien M.The reciprocal relationship between inflammation and coagulation.Top Companion Anim Med,2012;27(2):46-52.
  • 9Semeraro N,Ammollo CT,Semeraro F,et al.Sepsis,thrombosis and organ dysfunction.Thromb Res,2012;129(3):290-295.
  • 10Fry DE.Sepsis,systemic inflammatory response,and multiple organ dysfunction:the mystery continues.Am Surg,2012;78(1):1-8.

引证文献22

二级引证文献185

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部